Clinical Center; Notice of Meeting, 39964 [E9-19080]
Download as PDF
<![CDATA[
39964
Federal Register / Vol. 74, No. 152 / Monday, August 10, 2009 / Notices
identified projects that are part of the
Critical Path Initiative.
This Cooperative Agreement ensures
substantial FDA involvement in this
program, and will include, but will not
be limited to, co-development of study
priorities, protocols, decisionmaking,
reports, and publications at specified
program milestones related to
performance. FDA will support research
covered by this document under the
authority of section 301 of the Public
Health Service Act (42 U.S.C. 341).
Administrative regulations found in 45
CFR parts 74 and/or 92 are applicable.
C. Eligibility Information
The following organization/institution
is eligible to apply: Critical Path
Institute.
Competition is limited because of
FDA’s ongoing collaboration with the
University of Utah and the Critical Path
Institute, in support of FDA’s Critical
Path Initiative, and the combined ability
of these parties to leverage existing
databases, specimen repositories,
clinical, and other technical expertise in
support of this program.
II. Award Information/Funds Available
A. Award Amount
It is anticipated that FDA will fund
this Cooperative Agreement up to $1.5
million (direct and indirect costs) in FY
09 based on the quality of the
application received and the availability
of Federal funds.
rmajette on DSK29S0YB1PROD with NOTICES
B. Length of Support
Funding beyond the first year (up to
5 years) will be noncompetitive and will
depend on: (1) Satisfactory performance
during the preceding year and (2) the
availability of Federal fiscal year funds.
III. Paper Application, Registration,
and Submission Information
To submit a paper application in
response to this FOA, applicants should
first review the full announcement
located at https://www.fda.gov/oc/
initiatives/criticalpath/. Persons
interested in applying for a grant may
obtain an application at https://
grants.nih.gov/grants/forms.htm.
For all paper application submissions,
the following steps are required:
• Step 1: Obtain a Dun and Bradstreet
(DUNS) Number
• Step 2: Register With Central
Contractor Registration
• Step 3: Register With Electronic
Research Administration (eRA)
Commons
Steps 1 and 2, in detail, can be found
at https://www07.grants.gov/applicants/
organization_registration.jsp. Step 3, in
detail, can be found at https://
VerDate Nov<24>2008
15:09 Aug 07, 2009
Jkt 217001
commons.era.nih.gov/commons/
registration/registrationInstructions.jsp.
After you have followed these steps,
submit paper applications to: Gladys M.
Bohler (see FOR FURTHER INFORMATION
AND ADDITIONAL REQUIREMENTS CONTACT).
Dated: August 4, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–19010 Filed 8–7–09; 8:45 am]
BILLING CODE 4160–01–P
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: August 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–19080 Filed 8–7–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Clinical Center; Notice of Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended to
discuss personnel matters, the
disclosure of which would constitute a
clearly unwarranted invasion of privacy.
National Institute of Mental Health;
Notice of Meeting
Name of Committee: NIH Advisory Board
for Clinical Research.
Date: September 21, 2009.
Open: 10 a.m. to 1:15 p.m.
Agenda: To review the Clinical Center
budget plans and updates on selected
organizational initiatives.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Closed: 1:15 p.m. to 2 p.m.
Agenda: To review and evaluate to discuss
personnel matters.
Place: National Institutes of Health,
Building 10, 10 Center Drive, CRC Medical
Board Room 4–2551, Bethesda, MD 20892.
Contact Person: Maureen E Gormley,
Executive Secretary, Mark O. Hatfield,
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892, (301) 496–2897.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Mental Health
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: September 24, 2009.
Open: 10 a.m. to 12 p.m.
Agenda: Presentation of NIMH Director’s
report and discussion on NIMH program and
policy issues.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Contact Person: Jane A. Steinberg, PhD,
Director, Division of Extramural Activities,
National Institute of Mental Health, NIH,
Neuroscience Center, 6001 Executive Blvd.,
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 74, Number 152 (Monday, August 10, 2009)]
[Notices]
[Page 39964]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19080]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended
to discuss personnel matters, the disclosure of which would constitute
a clearly unwarranted invasion of privacy.
Name of Committee: NIH Advisory Board for Clinical Research.
Date: September 21, 2009.
Open: 10 a.m. to 1:15 p.m.
Agenda: To review the Clinical Center budget plans and updates
on selected organizational initiatives.
Place: National Institutes of Health, Building 10, 10 Center
Drive, CRC Medical Board Room 4-2551, Bethesda, MD 20892.
Closed: 1:15 p.m. to 2 p.m.
Agenda: To review and evaluate to discuss personnel matters.
Place: National Institutes of Health, Building 10, 10 Center
Drive, CRC Medical Board Room 4-2551, Bethesda, MD 20892.
Contact Person: Maureen E Gormley, Executive Secretary, Mark O.
Hatfield, Clinical Research Center, National Institutes of Health,
Building 10, Room 6-2551, Bethesda, MD 20892, (301) 496-2897.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: August 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-19080 Filed 8-7-09; 8:45 am]
BILLING CODE 4140-01-P
